{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:35:33Z","timestamp":1790019333914,"version":"4.0.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"DOI":"10.13039\/501100003770","name":"Banca d'Italia","doi-asserted-by":"publisher","award":["12868\/17"],"award-info":[{"award-number":["12868\/17"]}],"id":[{"id":"10.13039\/501100003770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministry of Education, Universities and Research","doi-asserted-by":"publisher","award":["RBSI144MT"],"award-info":[{"award-number":["RBSI144MT"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sapienza University","award":["C26H15JT9X"],"award-info":[{"award-number":["C26H15JT9X"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbadis.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T14:25:10Z","timestamp":1530800710000},"page":"3181-3194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Biliverdin reductase-A impairment links brain insulin resistance with increased A\u03b2 production in an animal model of aging: Implications for Alzheimer disease"],"prefix":"10.1016","volume":"1864","author":[{"given":"Francesca","family":"Triani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tramutola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Allan","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Perluigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.07.005_bb0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0015","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1152\/jn.2001.85.2.708","article-title":"Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo","volume":"85","author":"Freir","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/1566524013363177","article-title":"Beta-amyloid, neuronal death and Alzheimer's disease","volume":"1","author":"Carter","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0025","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.91.8.3270","article-title":"A model for b-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease","volume":"91","author":"Hensley","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0030","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0035","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11597760-000000000-00000","article-title":"Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease","volume":"72","author":"de la Monte","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0055","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's beta-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0070","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/JMN:23:1-2:105","article-title":"BACEI: the beta-secretase enzyme in Alzheimer's disease","volume":"23","author":"R","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-2-22","article-title":"The Alzheimer's disease \u03b2-secretase enzyme, BACE1","volume":"2","author":"Vassar","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mcne.2001.1065","article-title":"The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta)","volume":"19","author":"Pastorino","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0090","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1242\/jcs.01422","article-title":"Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy","volume":"117","author":"von Arnim","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0095","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.1074\/jbc.M011116200","article-title":"Phosphorylation regulates intracellular trafficking of beta-secretase","volume":"276","author":"Walter","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-2008-15413","article-title":"The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches","volume":"15","author":"Cotman","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1471-4159.2011.07538.x","article-title":"Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease","volume":"120","author":"Barone","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.freeradbiomed.2015.12.012","article-title":"Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: a new paradigm","volume":"91","author":"Barone","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0115","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3892\/etm.2015.2391","article-title":"Expression of beta-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease","volume":"9","author":"Li","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172429","article-title":"Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: role of Nigella sativa oil and antidiabetic drugs","volume":"12","author":"Balbaa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0125","doi-asserted-by":"crossref","first-page":"22532","DOI":"10.1074\/jbc.M115.662908","article-title":"All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor kappaB (NFkappaB) signaling","volume":"290","author":"Wang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fnagi.2015.00207","article-title":"Differential contributions of ApoE4 and female sex to BACE1 activity and expression mediate Abeta deposition and learning and memory in mouse models of Alzheimer's disease","volume":"7","author":"Hou","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12640-011-9256-9","article-title":"BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Abeta antibody labeling of early-onset axon terminal pathology","volume":"21","author":"Cai","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0140","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.0502173102","article-title":"Human biliverdin reductase: a member of the insulin receptor substrate family with serine\/threonine\/tyrosine kinase activity","volume":"102","author":"Lerner-Marmarosh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0145","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.13-247015","article-title":"Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor","volume":"28","author":"Gibbs","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0150","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1096\/fj.201600330RR","article-title":"Interaction of human biliverdin reductase with Akt\/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation","volume":"30","author":"Miralem","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0160","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.bbadis.2014.05.025","article-title":"Early alterations in energy metabolism in the hippocampus of APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"1842","author":"Pedros","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12017-012-8199-5","article-title":"The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-beta plaque and glial pathology in a mouse model of Alzheimer's disease","volume":"15","author":"Long-Smith","year":"2013","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tips.2008.12.003","article-title":"Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin","volume":"30","author":"Kapitulnik","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0175","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.3544219","article-title":"Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease","volume":"235","author":"Selkoe","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0169-328X(91)90088-F","article-title":"Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis","volume":"10","author":"Johnstone","year":"1991","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0185","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.bbadis.2013.03.016","article-title":"A canine model of human aging and Alzheimer's disease","volume":"1832","author":"Head","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0197-4580(00)00093-2","article-title":"Region-specific age at onset of beta-amyloid in dogs","volume":"21","author":"Head","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2008.03.015","article-title":"Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease","volume":"45","author":"Cenini","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0200","doi-asserted-by":"crossref","first-page":"10929","DOI":"10.1074\/jbc.M010753200","article-title":"Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation","volume":"276","author":"Salim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0205","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.0800750105","article-title":"Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling","volume":"105","author":"Lerner-Marmarosh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0210","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-2011-110092","article-title":"Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment","volume":"25","author":"Barone","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbadis.2011.01.005","article-title":"Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment","volume":"1812","author":"Barone","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cellsig.2003.07.004","article-title":"Akt\/GSK3\u03b2 serine\/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations","volume":"16","author":"Ryder","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0225","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bbadis.2014.04.007","article-title":"Neuropathological role of PI3K\/Akt\/mTOR axis in Down syndrome brain","volume":"1842","author":"Perluigi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0235","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41467-017-02221-9","article-title":"Brain insulin resistance impairs hippocampal synaptic plasticity and memory by increasing GluA1 palmitoylation through FoxO3a","volume":"8","author":"Spinelli","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2012-121045","article-title":"HO-1\/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease","volume":"32","author":"Di Domenico","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0245","series-title":"Advances in Cell Aging and Gerontology","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1566-3124(08)60057-7","article-title":"Protein oxidation processes in aging brain","author":"Butterfield","year":"1997"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0250","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1074\/jbc.M111.279612","article-title":"Formation of ternary complex of human biliverdin reductase-protein kinase Cdelta-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-kappaB, and inducible nitric-oxidase synthase (iNOS)","volume":"287","author":"Gibbs","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0255","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1073\/pnas.0611236104","article-title":"Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I","volume":"104","author":"Flajolet","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0260","article-title":"Up-regulation of casein kinase 1epsilon is involved in tau pathogenesis in Alzheimer's disease","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0265","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-8993(00)02200-9","article-title":"Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain","volume":"865","author":"Yasojima","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0270","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0197-4580(00)00110-X","article-title":"Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases","volume":"21","author":"Schwab","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0275","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1471-4159.2011.07623.x","article-title":"Beta-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis","volume":"120","author":"Tan","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0280","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/01.WNL.0000065916.25128.25","article-title":"Insulin increases CSF Abeta42 levels in normal older adults","volume":"60","author":"Watson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0285","first-page":"58406","article-title":"J.S. Malter, beta-Amyloid degradation and Alzheimer's disease","volume":"2006","author":"Wang","year":"2006","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0290","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0295","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/jdi.12027","article-title":"Insulin resistance in the brain: a new therapeutic target for Alzheimer's disease","volume":"4","author":"Umegaki","year":"2013","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0300","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0305","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.2337\/dbi15-0011","article-title":"A key role of insulin receptors in memory","volume":"64","author":"De Felice","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0310","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2337\/db11-0499","article-title":"Amyloid-beta induces hepatic insulin resistance by activating JAK2\/STAT3\/SOCS-1 signaling pathway","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0315","doi-asserted-by":"crossref","first-page":"24698","DOI":"10.1074\/jbc.M111.326504","article-title":"The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cdelta activity: the peptides are inhibitors or substrate for the protein kinase C","volume":"287","author":"Miralem","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1476-4598-13-231","article-title":"Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis","volume":"13","author":"Schittek","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0325","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0002-9440(10)65219-4","article-title":"A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease","volume":"155","author":"Ghoshal","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0330","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-006-0049-9","article-title":"Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions","volume":"111","author":"Kannanayakal","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0335","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1471-4159.2005.03269.x","article-title":"Insulin modulates hippocampal activity-dependent synaptic plasticity in a N\u2011methyl\u2011d\u2011aspartate receptor and phosphatidyl\u2011inositol\u20113\u2011kinase\u2011dependent manner","volume":"94","author":"van der Heide","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0340","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front Neurosci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0345","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","article-title":"Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo","volume":"58","author":"Chiu","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0350","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuropharm.2011.06.003","article-title":"Insulin promotes dendritic spine and synapse formation by the PI3K\/Akt\/mTOR and Rac1 signaling pathways","volume":"61","author":"Lee","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0355","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer's disease and insulin resistance: translating basic science into clinical applications","volume":"123","author":"De Felice","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0360","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrn4019","article-title":"Hippocampal insulin resistance and cognitive dysfunction","volume":"16","author":"Biessels","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0365","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fnins.2018.00215","article-title":"Insulin resistance as a therapeutic target in the treatment of Alzheimer's disease: a state-of-the-art review","volume":"12","author":"Benedict","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0370","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","article-title":"Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?","volume":"71","author":"Akter","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0375","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s10072-015-2352-5","article-title":"Linking insulin with Alzheimer's disease: emergence as type III diabetes","volume":"36","author":"Ahmed","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0380","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","article-title":"Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease","volume":"10","author":"de la Monte","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0385","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","article-title":"Type 3 diabetes is sporadic Alzheimers disease: mini-review","volume":"24","author":"de la Monte","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0390","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0196-9781(90)90044-6","article-title":"Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats","volume":"11","author":"Schwartz","year":"1990","journal-title":"Peptides"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0395","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jcem-64-1-190","article-title":"Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man","volume":"64","author":"Wallum","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0400","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ecl.2013.09.006","article-title":"Relationships between diabetes and cognitive impairment","volume":"43","author":"de la Monte","year":"2014","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.02.048","article-title":"Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease","volume":"490","author":"Watson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.003","article-title":"Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease","volume":"58","author":"Velazquez","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0415","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1096\/fj.14-268482","article-title":"Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease","volume":"29","author":"Vandal","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0420","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11357-010-9183-3","article-title":"Neurobiology of the aging dog","volume":"33","author":"Head","year":"2011","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0425","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1101\/lm.41701","article-title":"Effect of age and level of cognitive function on spontaneous and exploratory behaviors in the beagle dog","volume":"8","author":"Siwak","year":"2001","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0430","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1292\/jvms.54.29","article-title":"An immunohistochemical and ultrastructural study on age-related astrocytic gliosis in the central nervous system of dogs","volume":"54","author":"Shimada","year":"1992","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0435","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s004010050796","article-title":"Lectin histochemistry in the aged dog brain","volume":"95","author":"Kiatipattanasakul","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0440","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00401-006-0052-1","article-title":"Canine cognitive deficit correlates with diffuse plaque maturation and S100beta (\u2212) astrocytosis but not with insulin cerebrospinal fluid level","volume":"111","author":"Pugliese","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0445","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2006.12.090","article-title":"Canine cognitive dysfunction and the cerebellum: acetylcholinesterase reduction, neuronal and glial changes","volume":"1139","author":"Pugliese","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0450","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1292\/jvms.70.965","article-title":"Changes in glial fibrillary acidic protein immunoreactivity in the dentate gyrus and hippocampus proper of adult and aged dogs","volume":"70","author":"Hwang","year":"2008","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0455","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neurobiolaging.2007.10.017","article-title":"Implications of age and diet on canine cerebral cortex transcription","volume":"30","author":"Swanson","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2018.07.005_bb0460","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1939-165X.1990.tb00535.x","article-title":"The effects of aging on hematology and serum chemistry values in the beagle dog","volume":"19","author":"Lowseth","year":"1990","journal-title":"Vet. Clin. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0465","first-page":"980","article-title":"Serum chemistry values of normal dogs (beagles): associations with age, sex, and family line","volume":"27","author":"Kaspar","year":"1977","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0470","doi-asserted-by":"crossref","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","article-title":"Biliverdin reductase A Attenuates hepatic steatosis by inhibition of glycogen synthase kinase (GSK) 3beta phosphorylation of serine 73 of peroxisome proliferator-activated receptor (PPAR) alpha","volume":"291","author":"Hinds","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0475","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tem.2015.02.001","article-title":"Biliverdin reductase isozymes in metabolism","volume":"26","author":"O'Brien","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102147","article-title":"Diabetes-induced dysfunction of mitochondria and stem cells in skeletal muscle and the nervous system","volume":"18","author":"Fujimaki","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0485","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-94-007-2869-1_10","article-title":"Mitochondria and diabetes. An intriguing pathogenetic role","volume":"942","author":"Newsholme","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0490","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmet.2018.01.013","article-title":"Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-beta uptake in astrocytes","volume":"9","author":"Logan","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbadis.2018.07.005_bb0495","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/ars.2016.6759","article-title":"The triangle of death in Alzheimer's disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics","volume":"26","author":"Di Domenico","year":"2017","journal-title":"Antioxid. Redox Signal."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:42:29Z","timestamp":1760416949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918302333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0925443918302333"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biliverdin reductase-A impairment links brain insulin resistance with increased A\u03b2 production in an animal model of aging: Implications for Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}